Stockreport

ESPR Settles Nexletol/Nexlizet Patent Litigation With RDY, Stock Up [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF Reddy's Laboratories RDY related to patents for the marketed drugs, Nexletol (bempedoic acid) and Nexlizet (bempedoic acid and ezetimibe). Per the settlement terms, Dr [Read more]